4D Molecular Therapeutics (NASDAQ:FDMT) Trading Down 5.2%

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s share price dropped 5.2% during trading on Wednesday . The stock traded as low as $21.99 and last traded at $22.06. Approximately 128,644 shares were traded during trading, a decline of 73% from the average daily volume of 480,035 shares. The stock had previously closed at $23.26. […]

Related Keywords

United States ,Switzerland ,Swiss ,America ,Scott Bizily ,Jacob Chacko ,Metlife Investment Management ,Jpmorgan Chase Co ,D Molecular Therapeutics Inc ,York Mellon Corp ,Nasdaq ,Securities Exchange Commission ,Swiss National Bank ,Molecular Therapeutics ,Get Rating ,Molecular Therapeutics Trading Down ,Exchange Commission ,Director Jacob Chacko ,National Bank ,New York Mellon Corp ,Life Investment Management ,Rhumbline Advisers ,Molecular Therapeutics Daily ,